Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study

/unibl/sci/idNaucniRad:24182

616.36-002(497.6RS)

Pronađite slične unoseAcademic Article

Pronađite slične unosetext

Pronađite slične unose2019-02

A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, Scripta Medica, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019

77

81

Scripta Medica

xxxx-xxxx